Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001075497 | SCV001241121 | likely pathogenic | Retinal dystrophy | 2018-11-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003645884 | SCV004447917 | pathogenic | Saldino-Mainzer syndrome | 2023-11-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg137*) in the IFT140 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IFT140 are known to be pathogenic (PMID: 22503633, 23418020, 24009529, 26216056). This variant is present in population databases (rs762817061, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with IFT140-related conditions (PMID: 36460718). ClinVar contains an entry for this variant (Variation ID: 867028). For these reasons, this variant has been classified as Pathogenic. |
Ce |
RCV003883548 | SCV004701659 | likely pathogenic | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | IFT140: PVS1, PM2:Supporting |
Fulgent Genetics, |
RCV005021433 | SCV005645306 | likely pathogenic | Saldino-Mainzer syndrome; Retinitis pigmentosa 80 | 2024-04-03 | criteria provided, single submitter | clinical testing |